Vertigo Vestibular
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease (NCT04674735) | Apsen Farmaceutica S.A. | 2023-01-01 |
Track Vertigo Vestibular automatically
Every clearance here is in the API, with alerts when new ones post.